PON1 and chronic kidney disease: In the current study, we provide evidence of a significant reduction in HDL‐associated antioxidant PON‐1 activity (as quantified by both serum arylesterase and PON activity) in a large cohort of stable mild–moderate CKD patients undergoing elective coronary angiography, compared with age‐ and sex‐matched control subjects without CKD.